The following is an activator of LCAT
**Core Concept**
Phospholipid metabolism in the high-density lipoprotein (HDL) pathway involves the activation of lecithin-cholesterol acyltransferase (LCAT), an enzyme crucial for cholesterol esterification and HDL maturation.
**Why the Correct Answer is Right**
LCAT is activated by apolipoprotein A-I (ApoA-I), the primary protein component of HDL. When ApoA-I binds to LCAT, it facilitates the enzyme's interaction with its substrate, lecithin (phosphatidylcholine), and enables the transfer of an acyl group from the sn-2 position of lecithin to the 3-hydroxyl group of cholesterol, forming cholesterol ester. This process is essential for the formation of mature HDL particles and the promotion of reverse cholesterol transport.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because, while ApoA-I is a crucial activator of LCAT, it is not the only protein that interacts with LCAT. However, among the options provided, this is the closest to the correct answer.
**Option B:** Incorrect because cholesteryl ester transfer protein (CETP) is involved in the transfer of cholesteryl esters from HDL to low-density lipoproteins (LDL) and very-low-density lipoproteins (VLDL) in exchange for triglycerides, but it does not activate LCAT.
**Option C:** Incorrect because acyl-CoA:cholesterol acyltransferase (ACAT) is an enzyme involved in the formation of cholesterol esters within cells, but it is not directly related to the activation of LCAT.
**Clinical Pearl / High-Yield Fact**
ApoA-I is the primary activator of LCAT, and its levels are inversely correlated with the risk of cardiovascular disease. Maintaining high levels of ApoA-I through lifestyle modifications and, if necessary, pharmacological interventions can help promote the formation of mature HDL particles and reduce the risk of atherosclerotic cardiovascular disease.
**Correct Answer: A. Apolipoprotein A-I**